1 2004 Vol: 79(1). DOI: 10.1590/S0365-05962004000100004

Anticorpo anticitoplasma de neutrófilos (ANCA) em pioderma gangrenoso, um marcador sorológico para associação com doenças sistêmicas: estudo de oito casos

BACKGROUND: The pathogenesis of Ulcerative Colitis (UC) and its extraintestinal manifestations remain uncertain, although involvement of the immune system is emphasized. The likely importance of neutrophils is demonstrated by detection of the antineutrophil cytoplasmic antibody (ANCA) in this inflammatory bowel disease. Pyoderma Gangrenosum (PG) is an idiopathic skin condition and a rare cutaneous manifestation of UC. ANCA has also been reported in the latter dermatosis. OBJECTIVES: To invetigate the relationship between clinical features of UC and the appearance of PG and its association with ANCA. PATIENTS AND METHODS: ANCA was determined in sera from eight patients with PG. Four out of eight patients had pyoderma gangrenosum associated-UC, and in four cases no identified systemic disease was associated. RESULTS: The search for ANCA yielded negative results in sera from all four patients with pyoderma not associated with systemic disease. Two cases with active and extensive colitis associated with PG and primary sclerosing cholangitis (PSC) were positive for ANCA. Sera from two other patients with both UC and PG had negative test results. CONCLUSIONS: The presence of ANCA in patients with PG associated with UC and PSC suggests that its association with PSC is responsible for ANCA positivity in this subset of patients.

  1. Lerner J, Lerner M, Pasternack WA. Pyoderma gangrenosum. J Foot Ankle Surg32 , 569-72 (1993) .
  2. Schwaegerle SM, Bergfeld WF, Senitzer D, Tidrick RT. Pyoderma gangrenosum: A review. J Am Acad Dermatol 18 , 559-68 (1988) .
  3. Asghar SS, Bos JD, Kammeijer A, Cormane RH. Immunologic and biochemical studies on a patient with pyoderma gangrenosum. Int J Dermatol23 , 112-6 (1984) .
  4. Prytowsky JH, Kahn SN, Lazarus GS. Present status of pyoderma gangrenosum. Arch Dermatol125:57- 64 , (1989) .
  5. Johnson ML, Grimwood RE. Leukocyte colony - stimulating factors: A review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol130:77- 81 , (1994) .
  6. Callen J P. Pyoderma gangrenosum and related disorders. Med. Clin of North America73 , 1247-60 (1989) .
  7. Janowitz HD. Pyoderma gangrenosum. Lancet351:1134 , (1998) .
  8. Sheldon DG, Sawchuk LL, Kozarek RA, Thirlby RC. Twenty cases of peristomal pyoderma gangrenosum diagnostic implications and management. Arch Surg135 , 564-8 (2000) .
  9. Thornton JR, Teague RH, Low-Beer TS, Read A. E. Pyoderma gangrenosum and ulcerative colitis. Gut21:247- 8 , (1980) .
  10. Levitt MD, Ritchie JK, Lennard-Jones JE, Phillips RKS. Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg78 , 676-8 (1991) .
  11. Hoffman MD. Pyoderma gangrenosum associated with c-ANCA (h-lamp-2). Int J Dermatol40 , 135-7 (2001) .
  12. Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis. A study of 42 patients. Am. J. Gastroenterol.80:615- 20 , (1985) .
  13. Von Den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 137 , 1000-5 (1997) .
  14. Gibson LE, Daoud MS, Muller SA et al. Malignant Pyodermas Revisited. Mayo Clin Proc72 , 734-6 (1997) .
  15. Powell FC, O'Kane M. Management of Pyoderma Gangrenosum. Dermatol Clin20(2) , 347-55 (2002) .
  16. Bayle P, Laplanche G, Gorguet B et al. Neutrophilic dermatosis: A case of overlapping syndrome with monoclonal antineutrophil cytoplasmic autoantibody activity. Dermatology189 , 69-71 (1994) .
  17. Kemmett D, Harrison DJ, Hunter JAA. Antibodies to neutrophil cytoplasmic antigens: A serologic marker for Sweet's syndrome. J Am Acad Dermatol24:967- 9 , (1991) .
  18. Duerr RH, Targan SR, Landers CJ et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/diarrheal illnesses. Gastroenterology100:1590- 6 , (1991) .
  19. Terjune B, Spengler U, Saverbruch T, Worman H. Atypical p-ANCA in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology119 , 310-22 (2000) .
  20. Van der Woude FJ, Rasmussen N, Lobatto S et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. LancetI , 425-9 (1985) .
  21. Jennette JC, Falk RJ. Diagnostic classification of antineutrophil cytoplasmic autoantibody - associated vasculitides. Am J Kidney Dis 18 , 184-7 (1991) .
  22. Savige J, Gillis D, Benson E et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 111 , 507-13 (1999) .
  23. Pollock W, Clarke K, Gallagher K et al. Immunofluorescent patterns by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate. J Clin Pathol55(9) , 680-3 (2002) .
  24. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Br Med J2:1041- 8 , (1955) .
  25. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS97 , 12-5 (1989) .
  26. Veloso FT, Carvalho J, Magro F. Immune related systemic manifestations of inflammatory bowel disease. J Clin Gastroenterol23(1) , 29-34 (1997) .
  27. Rump JA, Wörner I, Roth M et al. P-ANCA of undefined specificity in ulcerative colitis: correlation to disease activity and therapy. Adv Exp Med Biol336 , 507-12 (1993) .
  28. Chowdhury SMZ, Broomhead V, Spickett GP, Wilkinson R. Pitfalls of formalin fixation for determination of antineutrophil cytoplasmic antibodies. J Clin Pathol52 , 475-7 (1999) .
  29. Irvine AD, Bruce IN, Walsh M. Dermatological presentation of disease associated with antineutrophil cytoplasmic antibodies: A report of two contrasting cases and review of the literature. Br J Dermatol134:924- 8 , (1996) .
  30. Thieme U, Sima D, Göbel U et al. Anca in pyoderma gangrenosum (PG). Clin Exp Immunol101:69 (abstract) , (1995) .